Small molecule • Aging & cellular biology
Sirolimus
Also called Rapamycin
What it is, the potential benefits being studied, and what the evidence supports right now.
Early human research•Used medically for a specific purpose
01 • Start here
Potential benefits being studied.
Transplant medicine, lymphangioleiomyomatosis, and experimental aging hypotheses.
- Strength & performance
- Cellular energy & aging
- Immunity & inflammation
02 • Why it stands out
The simple explanation.
Sirolimus is getting attention for transplant medicine, lymphangioleiomyomatosis, and experimental aging hypotheses.
03 • Research highlight
Why researchers are interested.
Early work in people makes transplant medicine, lymphangioleiomyomatosis, and experimental aging hypotheses the main reason to keep watching Sirolimus.
Evidence detailsStudy limits, status, and safety context
Study summary: Its approved uses are supported by clinical evidence, and early human aging studies are exploring immune function, physical performance, and related biomarkers.
What to keep in mind: Animal lifespan results do not define a safe human anti-aging use; immunosuppression and other adverse effects matter.
Potential benefits describe research questions, not a promise that a product will produce the same result in a person.